Letter to the Editor: Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment

被引：0
|
作者：
Liu, Qingran [1 ]
Li, Jinpeng [2 ]
Chen, Hua [2 ]
Song, Jinlong [2 ]
机构：
[1] Shandong First Med Univ, Binzhou Peoples Hosp, Dept Intervent Med, Binzhou, Shandong, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Intervent Therapy 1, Jinan 250117, Shandong, Peoples R China
来源：
HEPATOLOGY | 2025年 / 81卷 / 03期
关键词：
D O I：
10.1097/HEP.0000000000001215
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E101 / E102
页数：2
相关论文
共 50 条
  • [41] Increased Spleen Volume in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab in Comparison to Lenvatinib: A Retrospective Analysis
    Hatanaka, Takeshi
    Naganuma, Atsushi
    Furusawa, Ai
    Tamura, Yuki
    Saito, Naoto
    Suzuki, Yuhei
    Hoshino, Takashi
    Yata, Yutaka
    Uraoka, Toshio
    Kakizaki, Satoru
    ONCOLOGY, 2023, 101 (03) : 193 - 202
  • [42] Real-world systemic treatment patterns of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma (HCC)
    Singal, A. G.
    Ozgurdal, K.
    Fan, X.
    Vassilev, Z.
    Chen, C-C.
    Multani, J. K.
    Zhou, Z.
    He, J.
    Pisa, F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S867 - S867
  • [43] ASSESSING ATEZOLIZUMAB PLUS BEVACIZUMAB TREATMENT FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA PATIENTS WITH ESOPHAGEAL-GASTRIC VARICES
    Tada, Fujimasa
    Hiraoka, Atsushi
    Hatanaka, Takeshi
    Tada, Toshifumi
    Kakizaki, Satoru
    Kumada, Takashi
    GASTROENTEROLOGY, 2024, 166 (05) : S1730 - S1730
  • [44] The efficacy of atezolizumab plus bevacizumab in the treatment of unresectable hepatocellular carcinoma in cirrhotic and non-cirrhotic patients
    Aranda-Gutierrez, Alejandro
    Conde-Flores, Emilio
    Meraz-Brenez, Andres
    Escorza, Salvador
    Meneses-Medina, Monica I. Isabel
    Huitzil-Melendez, Fidel David
    de la Mora-Molina, Hector
    Rosas Camargo, Vanessa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] RECIST 1.1, mRECIST, and Choi criteria for evaluating treatment response and survival outcomes in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab
    Kim, Dong Hwan
    Min, Eun Jeong
    Kim, Bohyun
    Choi, Jong Young
    Jang, Jeong Won
    Sung, Pil Soo
    Han, Ji Won
    Kim, Hokun
    Choi, Joon-Il
    EUROPEAN RADIOLOGY, 2025, 35 (02) : 684 - 694
  • [46] RECIST 1.1, mRECIST, and Choi criteria for evaluating treatment response and survival outcomes in hepatocellular carcinoma patients treated with Atezolizumab plus Bevacizumab
    Kim, Bohyun
    Kim, Dong Hwan
    Moon, Eun Jeong
    Choi, Joon-Il
    Choi, Jong Young
    JOURNAL OF HEPATOLOGY, 2024, 80 : S448 - S449
  • [47] Outcomes and safety of DAA treatment in HCV cirrhotic patients treated with Atezolizumab- Bevacizumab for hepatocellular carcinoma
    Stella, L.
    Cabibbo, G.
    Iavarone, M.
    Piscaglia, F.
    Tovoli, F.
    Marra, F.
    Mazzarelli, C.
    Tortora, R.
    Aghemo, A.
    De Nicola, S.
    Bhoori, S.
    Pallozzi, M.
    Gasbarrini, A.
    Cerrito, L.
    Ponziani, F. R.
    DIGESTIVE AND LIVER DISEASE, 2025, 57
  • [48] Dose-Reduction of Bevacizumab in Atezolizumab plus Bevacizumab Therapy Extends Treatment duration with Disease Control in Patients with Hepatocellular Carcinoma
    Sakai, Miwa
    Iwamoto, Hideki
    Shimose, Shigeo
    Niizeki, Takashi
    Nakano, Masahito
    Shirono, Tomotake
    Noda, Yu
    Moriyama, Etsuko
    Suzuki, Hiroyuki
    Koga, Hironori
    Kuromatsu, Ryoko
    Kawaguchi, Takumi
    ONCOLOGY, 2024,
  • [49] PROGNOSTIC IMPACT OF THE PROGRESSION OF LUNG METASTASIS AFTER THE FIRST CYCLE OF ATEZOLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Yang, Jiwon
    Choi, Jonggi
    Choi, Won-Mook
    Kim, Kang Mo
    Lee, Han Chu
    Shim, Ju Hyun
    HEPATOLOGY, 2023, 78 : S1877 - S1878
  • [50] Impact of Atezolizumab plus Bevacizumab Therapy on Health-Related Quality of Life in Patients with Advanced Hepatocellular Carcinoma
    Shomura, Masako
    Okabe, Haruka
    Sakakibara, Maya
    Sato, Emi
    Shiraishi, Koichi
    Arase, Yoshitaka
    Tsuruya, Kota
    Mishima, Yusuke
    Hirose, Shunji
    Kagawa, Tatehiro
    CANCERS, 2024, 16 (21)
12345